Literature DB >> 1600042

Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients.

M Tatsuta1, H Iishi, A Nakaizumi, S Okuda.   

Abstract

The effects on gastric emptying and gastrointestinal symptoms of treatment with cisapride alone and in combination with domperidone were investigated in 25 patients with chronic idiopathic dyspepsia. In a double-blind study, 9 patients were randomly assigned to receive cisapride 2.5 mg three times daily, and 8 patients to receive placebo. After 7 days of treatment, gastric emptying was significantly accelerated and the score of gastrointestinal symptoms was significantly reduced in patients treated with cisapride. Placebo treatment had no significant effect. A randomized, double-blind crossover study of 8 patients compared the effects of combined treatment with cisapride 2.5 mg plus domperidone 10 mg three times daily for 7 days against the effects of cisapride plus placebo. Administration of cisapride plus domperidone gave significantly higher gastric emptying and lower gastrointestinal symptoms than cisapride plus placebo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600042     DOI: 10.1111/j.1365-2036.1992.tb00265.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

Review 1.  Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists.

Authors:  Paul Kuo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Single oral dose of cisapride accelerates gastric antral emptying in healthy humans: an ultrasonographic study.

Authors:  T Takeda; H Konomi; G Naritomi; J Yoshida; H Matsunaga; K Akazawa; M Tanaka
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

3.  A scintigraphic study on gastric emptying in patients with non-ulcer dyspepsia.

Authors:  S Wang; B Cheng; H Wu; Y Zheng; J Hu; J Zhou; Z Xianyu
Journal:  J Tongji Med Univ       Date:  1996

4.  Treatment of functional dyspepsia.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

Review 5.  H(2) receptor antagonists and prokinetics in dyspepsia: a critical review.

Authors:  Peter Bytzer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 6.  Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia.

Authors:  Hiroto Miwa
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

7.  Functional Dyspepsia: A New Rome III Paradigm.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

Review 8.  Diabetic gastroparesis: diagnosis and management.

Authors:  Jing Ma; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

Review 9.  Functional dyspepsia. Current treatment recommendations.

Authors:  Gerald Holtmann; Nicholas J Talley
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 10.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.